
CASE DISCUSSION
Management of Diabetic Keto-Acidosis in Critically ill Patients
Views
152,974
Credit Points
Learning Hours
CPD Points
CME Points
Courses Completed
Case Description
Management of DKA in critically ill patients requires rapid recognition, hemodynamic stabilization, and correction of metabolic derangements. Initial treatment includes aggressive fluid resuscitation with isotonic saline to restore perfusion, followed by insulin infusion to suppress ketogenesis and...
Case Summary
- Diabetic ketoacidosis (DKA) is defined by hyperglycemia, ketosis (blood or urine), and metabolic acidosis. It must be differentiated from hyperglycemic hyperosmolar state (HHS), which involves hyperglycemia and hyperosmolarity but lacks significant ketosis or acidosis. DKA severity is stratified as mild, moderate, or severe based on glucose levels, ketonemia, and acidosis (pH or bicarbonate). Not all criteria must be fulfilled to define a DKA as mild moderate or severe.
Speaker Profile

Dr. Prof. Mathieu Jozwaik
Intensive Care Medicine University Hospital Center, FranceDr. Prof. Mathieu Jozwaik is a distinguished specialist in Intensive Care Medicine at the University Hospital Center, France. With extensive expertise in managing critically ill patients, he is recognized for his contributions to advanced intensive care practices and for bringing clinical excellence and innovation to critical care delivery in France.
Disclosures
Assimilate requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant financial relationships for anyone with the ability to control the content of this educational activity have been reviewed and mitigated. Others involved in the planning of this activity have no relevant financial relationships.